| Financial Year |
March 31 2023 |
| Monetary Funds |
218,041,911.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
345,368,754.07 |
| Advances to Suppliers |
12,761,197.02 |
| Other Receivables |
8,168,332.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
628,807,118.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,436,197.43 |
| Total Current Assets |
1,265,003,870.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
43,329,570.41 |
| Investment Properties |
-- |
| Fixed Assetes |
8,285,812.32 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,631,776.02 |
| R&D expenses |
-- |
| Goodwill |
43,779,024.83 |
| Long-Term Deferred and Prepaid Expenses |
1,651,997.07 |
| Deferred Income Tax Assets |
16,631,707.91 |
| Other Non-Current Assets |
3,020,410.13 |
| Sub-Total of Non-Current Assets |
155,177,635.81 |
| Total Assets |
1,420,181,506.05 |
| Short-Term Loans |
335,080,409.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,341,180.00 |
| Accounts Payable |
78,289,692.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
55,503,988.42 |
| Taxes Payable |
7,595,062.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
58,594,657.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,325,444.21 |
| Other Current Liabilities |
22,209,136.38 |
| Sub-Total of Current Liabilities |
754,727,668.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,096,341.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,544,264.13 |
| Total Liabilities |
777,271,932.95 |
| Paid-In Capital(Or Share Stock) |
446,762,257.00 |
| Capital Surplus |
346,660,841.48 |
| Surplus Reserve |
23,896,061.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-189,629,271.77 |
| Minority Stockholder's Interest |
14,993,688.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
627,915,884.82 |
| Owner's Equity（Stockholder's Equity） |
642,909,573.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,420,181,506.05 |
